欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/2038/001
药品名称Mometasone Furoate 50 mcg/1 dos Nasal spray, suspension
活性成分
    • Mometasone furoate 50.0 µg
剂型Nasal spray, suspension
上市许可持有人Sandoz B.V. Hospitaaldreef 29 1315 RC Almere Nederland
参考成员国 - 产品名称Netherlands (NL)
Mometasonfuroaat Sandoz 50 microgram/dosis, neusspray, suspensie
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Mometasone Sandoz
    • Estonia (EE)
      NASOMETIN
    • Hungary (HU)
      MOMETASON SANDOZ 50 mikrogramm/adag szuszpenziós orrspray
    • Czech Republic (CZ)
      Mometasone Furoate Sandoz
    • Romania (RO)
      Mometazona furoat Sandoz 50 μg/doza, spray nazal, suspensie
    • Slovak Republic (SK)
      Mometasone Sandoz 50 mikrogramov
    • Slovenia (SI)
      Mommox 50 mikrogramov/vpih pršilo za nos, suspenzija
许可日期2012/10/08
最近更新日期2025/12/17
药物ATC编码
    • R01AD09 mometasone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase